Key details
Sponsor
Encore Medical Inc.
Collaborators
Bright Research Partners, Yale Cardiovascular Research Group
Enrollment target
~500 participants
Primary completion
April 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 60 Years
Last updated September 2024